{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:37:58Z","timestamp":1794073078742,"version":"4.8.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T00:00:00Z","timestamp":1581984000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630099"],"award-info":[{"award-number":["81630099"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Oxidative stress is a major pathogenic mechanism in Parkinson\u2019s disease (PD). As an important cellular antioxidant, glutathione (GSH) balances the production and incorporation of free radicals to protect neurons from oxidative damage. GSH level is decreased in the brains of PD patients. Hence, clarifying the molecular mechanism of GSH deficiency may help deepen our knowledge of PD pathogenesis. Here we report that the astrocytic dopamine D2 receptor (DRD2) regulates GSH synthesis via PKM2-mediated Nrf2 transactivation. In addition we find that pyridoxine can dimerize PKM2 to promote GSH biosynthesis. Further experiments show that pyridoxine supplementation increases the resistance of nigral dopaminergic neurons to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurotoxicity in wild-type mice as well as in astrocytic Drd2 conditional knockout mice. We conclude that dimerizing PKM2 may be a potential target for PD treatment.<\/jats:p>","DOI":"10.1038\/s41467-020-14788-x","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T06:04:08Z","timestamp":1582005848000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":190,"title":["Pyridoxine induces glutathione synthesis via PKM2-mediated Nrf2 transactivation and confers neuroprotection"],"prefix":"10.1038","volume":"11","author":[{"given":"Yao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoran","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanshan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,18]]},"reference":[{"key":"14788_CR1","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrn.2017.25","volume":"18","author":"S Przedborski","year":"2017","unstructured":"Przedborski, S. The two-century journey of Parkinson disease research. Nat. Rev. Neurosci. 18, 251\u2013259 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"14788_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1126\/science.1087753","volume":"302","author":"TM Dawson","year":"2003","unstructured":"Dawson, T. M. & Dawson, V. L. Molecular pathways of neurodegeneration in Parkinson\u2019s disease. Science 302, 819\u2013822 (2003).","journal-title":"Science"},{"key":"14788_CR3","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1046\/j.1471-4159.1997.69031196.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam, Z. I. et al. Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J. Neurochem. 69, 1196\u20131203 (1997).","journal-title":"J. Neurochem."},{"key":"14788_CR4","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1111\/j.1471-4159.1989.tb09133.x","volume":"52","author":"DT Dexter","year":"1989","unstructured":"Dexter, D. T. et al. Basal lipid peroxidation in substantia nigra is increased in Parkinson\u2019s disease. J. Neurochem. 52, 381\u2013389 (1989).","journal-title":"J. Neurochem."},{"key":"14788_CR5","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1046\/j.1471-4159.1997.69031326.x","volume":"69","author":"ZI Alam","year":"1997","unstructured":"Alam, Z. I. et al. A generalised increase in protein carbonyls in the brain in Parkinson\u2019s but not incidental Lewy body disease. J. Neurochem. 69, 1326\u20131329 (1997).","journal-title":"J. Neurochem."},{"key":"14788_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong, Y. C. & Krainc, D. alpha-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat. Med. 23, 1\u201313 (2017).","journal-title":"Nat. Med."},{"key":"14788_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/science.aar6606","volume":"360","author":"C Arkinson","year":"2018","unstructured":"Arkinson, C. & Walden, H. Parkin function in Parkinson\u2019s disease. Science 360, 267\u2013268 (2018).","journal-title":"Science"},{"key":"14788_CR8","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/nature09536","volume":"468","author":"JN Guzman","year":"2010","unstructured":"Guzman, J. N. et al. Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature 468, 696\u2013700 (2010).","journal-title":"Nature"},{"key":"14788_CR9","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla, L. F. et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357, 1255\u20131261 (2017).","journal-title":"Science"},{"key":"14788_CR10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0301-0082(99)00060-X","volume":"62","author":"R Dringen","year":"2000","unstructured":"Dringen, R. Metabolism and functions of glutathione in brain. Prog. Neurobiol. 62, 649\u2013671 (2000).","journal-title":"Prog. Neurobiol."},{"key":"14788_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.freeradbiomed.2013.05.001","volume":"62","author":"M Smeyne","year":"2013","unstructured":"Smeyne, M. & Smeyne, R. J. Glutathione metabolism and Parkinson\u2019s disease. Free Radic. Biol. Med 62, 13\u201325 (2013).","journal-title":"Free Radic. Biol. Med"},{"key":"14788_CR12","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1042\/bj20021614","volume":"370","author":"S Filosa","year":"2003","unstructured":"Filosa, S. et al. Failure to increase glucose consumption through the pentose-phosphate pathway results in the death of glucose-6-phosphate dehydrogenase gene-deleted mouse embryonic stem cells subjected to oxidative stress. Biochem. J. 370, 935\u2013943 (2003).","journal-title":"Biochem. J."},{"key":"14788_CR13","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0304-3940(86)90320-4","volume":"67","author":"TL Perry","year":"1986","unstructured":"Perry, T. L. & Yong, V. W. Idiopathic Parkinson\u2019s disease, progressive supranuclear palsy and glutathione metabolism in the substantia nigra of patients. Neurosci. Lett. 67, 269\u2013274 (1986).","journal-title":"Neurosci. Lett."},{"key":"14788_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/0304-3940(92)90355-B","volume":"142","author":"E Sofic","year":"1992","unstructured":"Sofic, E., Lange, K. W., Jellinger, K. & Riederer, P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson\u2019s disease. Neurosci. Lett. 142, 128\u2013130 (1992).","journal-title":"Neurosci. Lett."},{"key":"14788_CR15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.410360305","volume":"36","author":"J Sian","year":"1994","unstructured":"Sian, J. et al. Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36, 348\u2013355 (1994).","journal-title":"Ann. Neurol."},{"key":"14788_CR16","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11064-011-0619-7","volume":"37","author":"C Venkateshappa","year":"2012","unstructured":"Venkateshappa, C. et al. Increased oxidative damage and decreased antioxidant function in aging human substantia nigra compared to striatum: implications for Parkinson\u2019s disease. Neurochem. Res. 37, 358\u2013369 (2012).","journal-title":"Neurochem. Res."},{"key":"14788_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0006-8993(99)01688-1","volume":"838","author":"M Iida","year":"1999","unstructured":"Iida, M. et al. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 838, 51\u201359 (1999).","journal-title":"Brain Res."},{"key":"14788_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1023\/A:1007672414239","volume":"26","author":"K Tanaka","year":"2001","unstructured":"Tanaka, K. et al. Molecular mechanism in activation of glutathione system by ropinirole, a selective dopamine D2 agonist. Neurochem. Res. 26, 31\u201336 (2001).","journal-title":"Neurochem. Res."},{"key":"14788_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0168-0102(02)00040-8","volume":"43","author":"M Yoshioka","year":"2002","unstructured":"Yoshioka, M. et al. The dopamine agonist cabergoline provides neuroprotection by activation of the glutathione system and scavenging free radicals. Neurosci. Res. 43, 259\u2013267 (2002).","journal-title":"Neurosci. Res."},{"key":"14788_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/glia.440010606","volume":"1","author":"E Hansson","year":"1988","unstructured":"Hansson, E. & Ronnback, L. Neurons from substantia nigra increase the efficacy and potency of second messenger arising from striatal astroglia dopamine receptor. Glia 1, 393\u2013397 (1988).","journal-title":"Glia"},{"key":"14788_CR21","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/0169-328X(94)90227-5","volume":"23","author":"A Bal","year":"1994","unstructured":"Bal, A. et al. Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: in situ hybridization and polymerase chain reaction studies. Brain Res Mol. Brain Res 23, 204\u2013212 (1994).","journal-title":"Brain Res Mol. Brain Res"},{"key":"14788_CR22","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<544::AID-JNR7>3.0.CO;2-9","volume":"58","author":"P Zanassi","year":"1999","unstructured":"Zanassi, P., Paolillo, M., Montecucco, A., Avvedimento, E. V. & Schinelli, S. Pharmacological and molecular evidence for dopamine D(1) receptor expression by striatal astrocytes in culture. J. Neurosci. Res. 58, 544\u2013552 (1999).","journal-title":"J. Neurosci. Res."},{"key":"14788_CR23","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature11748","volume":"494","author":"W Shao","year":"2013","unstructured":"Shao, W. et al. Suppression of neuroinflammation by astrocytic dopamine D2 receptors via alphaB-crystallin. Nature 494, 90\u201394 (2013).","journal-title":"Nature"},{"key":"14788_CR24","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1038\/s41418-018-0127-2","volume":"25","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. Dopamine D2 receptor restricts astrocytic NLRP3 inflammasome activation via enhancing the interaction of beta-arrestin2 and NLRP3. Cell Death Differ. 25, 2037\u20132049 (2018).","journal-title":"Cell Death Differ."},{"key":"14788_CR25","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1046\/j.1471-4159.1994.62010045.x","volume":"62","author":"TK Makar","year":"1994","unstructured":"Makar, T. K. et al. Vitamin E, ascorbate, glutathione, glutathione disulfide, and enzymes of glutathione metabolism in cultures of chick astrocytes and neurons: evidence that astrocytes play an important role in antioxidative processes in the brain. J. Neurochem. 62, 45\u201353 (1994).","journal-title":"J. Neurochem."},{"key":"14788_CR26","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1046\/j.1471-4159.2001.00374.x","volume":"77","author":"Y Chen","year":"2001","unstructured":"Chen, Y. et al. Astrocytes protect neurons from nitric oxide toxicity by a glutathione-dependent mechanism. J. Neurochem. 77, 1601\u20131610 (2001).","journal-title":"J. Neurochem."},{"key":"14788_CR27","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1046\/j.1471-4159.1999.0722523.x","volume":"72","author":"R Dringen","year":"1999","unstructured":"Dringen, R., Kussmaul, L., Gutterer, J. M., Hirrlinger, J. & Hamprecht, B. The glutathione system of peroxide detoxification is less efficient in neurons than in astroglial cells. J. Neurochem. 72, 2523\u20132530 (1999).","journal-title":"J. Neurochem."},{"key":"14788_CR28","doi-asserted-by":"publisher","first-page":"pe7","DOI":"10.1126\/scisignal.2003925","volume":"6","author":"DY Gui","year":"2013","unstructured":"Gui, D. Y., Lewis, C. A. & Vander Heiden, M. G. Allosteric regulation of PKM2 allows cellular adaptation to different physiological states. Sci. Signal 6, pe7 (2013).","journal-title":"Sci. Signal"},{"key":"14788_CR29","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.15252\/embr.201643300","volume":"17","author":"TL Dayton","year":"2016","unstructured":"Dayton, T. L., Jacks, T. & Vander Heiden, M. G. PKM2, cancer metabolism, and the road ahead. EMBO Rep. 17, 1721\u20131730 (2016).","journal-title":"EMBO Rep."},{"key":"14788_CR30","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.cell.2011.03.054","volume":"145","author":"W Luo","year":"2011","unstructured":"Luo, W. et al. Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1. Cell 145, 732\u2013744 (2011).","journal-title":"Cell"},{"key":"14788_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/nature10598","volume":"480","author":"W Yang","year":"2011","unstructured":"Yang, W. et al. Nuclear PKM2 regulates beta-catenin transactivation upon EGFR activation. Nature 480, 118\u2013122 (2011).","journal-title":"Nature"},{"key":"14788_CR32","doi-asserted-by":"crossref","unstructured":"Saleme, B., et al. Tissue-specific regulation of p53 by PKM2 is redox dependent and provides a therapeutic target for anthracycline-induced cardiotoxicity. Sci. Transl. Med. 11, eaau8866 (2019).","DOI":"10.1126\/scitranslmed.aau8866"},{"key":"14788_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","volume":"45","author":"X Gao","year":"2012","unstructured":"Gao, X., Wang, H., Yang, J. J., Liu, X. & Liu, Z. R. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell 45, 598\u2013609 (2012).","journal-title":"Mol. Cell"},{"key":"14788_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2012.07.018","volume":"150","author":"W Yang","year":"2012","unstructured":"Yang, W. et al. PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis. Cell 150, 685\u2013696 (2012).","journal-title":"Cell"},{"key":"14788_CR35","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.molcel.2014.02.015","volume":"53","author":"KE Keller","year":"2014","unstructured":"Keller, K. E., Doctor, Z. M., Dwyer, Z. W. & Lee, Y. S. SAICAR induces protein kinase activity of PKM2 that is necessary for sustained proliferative signaling of cancer cells. Mol. Cell 53, 700\u2013709 (2014).","journal-title":"Mol. Cell"},{"key":"14788_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.tibs.2018.01.006","volume":"43","author":"Z Lu","year":"2018","unstructured":"Lu, Z. & Hunter, T. Metabolic kinases moonlighting as protein kinases. Trends Biochem. Sci. 43, 301\u2013310 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"14788_CR37","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1586\/14737175.7.10.1391","volume":"7","author":"U Bonuccelli","year":"2007","unstructured":"Bonuccelli, U. & Pavese, N. Role of dopamine agonists in Parkinson\u2019s disease: an update. Expert Rev. Neurother. 7, 1391\u20131399 (2007).","journal-title":"Expert Rev. Neurother."},{"key":"14788_CR38","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tibs.2014.02.002","volume":"39","author":"JD Hayes","year":"2014","unstructured":"Hayes, J. D. & Dinkova-Kostova, A. T. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39, 199\u2013218 (2014).","journal-title":"Trends Biochem. Sci."},{"key":"14788_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2004.09.037","volume":"119","author":"BM Spiegelman","year":"2004","unstructured":"Spiegelman, B. M. & Heinrich, R. Biological control through regulated transcriptional coactivators. Cell 119, 157\u2013167 (2004).","journal-title":"Cell"},{"key":"14788_CR40","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nchembio.1060","volume":"8","author":"D Anastasiou","year":"2012","unstructured":"Anastasiou, D. et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nat. Chem. Biol. 8, 839\u2013847 (2012).","journal-title":"Nat. Chem. Biol."},{"key":"14788_CR41","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug Discov. 9, 373\u2013386 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"14788_CR42","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41589-018-0115-3","volume":"14","author":"F Yang","year":"2018","unstructured":"Yang, F. et al. Allosteric mechanisms underlie GPCR signaling to SH3-domain proteins through arrestin. Nat. Chem. Biol. 14, 876\u2013886 (2018).","journal-title":"Nat. Chem. Biol."},{"key":"14788_CR43","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41594-018-0071-3","volume":"25","author":"A Sente","year":"2018","unstructured":"Sente, A. et al. Molecular mechanism of modulating arrestin conformation by GPCR phosphorylation. Nat. Struct. Mol. Biol. 25, 538\u2013545 (2018).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"14788_CR44","doi-asserted-by":"publisher","first-page":"S167","DOI":"10.1002\/ana.410440725","volume":"44","author":"CW Olanow","year":"1998","unstructured":"Olanow, C. W., Jenner, P. & Brooks, D. Dopamine agonists and neuroprotection in Parkinson\u2019s disease. Ann. Neurol. 44, S167\u2013S174 (1998).","journal-title":"Ann. Neurol."},{"key":"14788_CR45","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.1097\/NRL.0b013e31823968fc","volume":"17","author":"MT Herrero","year":"2011","unstructured":"Herrero, M. T., Pagonabarraga, J. & Linazasoro, G. Neuroprotective role of dopamine agonists: evidence from animal models and clinical studies. Neurologist 17, S54\u2013S66 (2011).","journal-title":"Neurologist"},{"key":"14788_CR46","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12551-016-0244-4","volume":"9","author":"P Deshmukh","year":"2017","unstructured":"Deshmukh, P., Unni, S., Krishnappa, G. & Padmanabhan, B. The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases. Biophys. Rev. 9, 41\u201356 (2017).","journal-title":"Biophys. Rev."},{"key":"14788_CR47","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1038\/nrd.2018.136","volume":"17","author":"D Charvin","year":"2018","unstructured":"Charvin, D., Medori, R., Hauser, R. A. & Rascol, O. Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs. Nat. Rev. Drug Disco. 17, 804\u2013822 (2018).","journal-title":"Nat. Rev. Drug Disco."},{"key":"14788_CR48","doi-asserted-by":"publisher","first-page":"11929","DOI":"10.1523\/JNEUROSCI.1860-14.2014","volume":"34","author":"Y Zhang","year":"2014","unstructured":"Zhang, Y. et al. An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J. Neurosci. 34, 11929\u201311947 (2014).","journal-title":"J. Neurosci."},{"key":"14788_CR49","doi-asserted-by":"publisher","first-page":"329","DOI":"10.3390\/molecules14010329","volume":"14","author":"S Mooney","year":"2009","unstructured":"Mooney, S., Leuendorf, J. E., Hendrickson, C. & Hellmann, H. Vitamin B6: a long known compound of surprising complexity. Molecules 14, 329\u2013351 (2009).","journal-title":"Molecules"},{"key":"14788_CR50","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nature06734","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk, H. R. et al. The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth. Nature 452, 230\u2013233 (2008).","journal-title":"Nature"},{"key":"14788_CR51","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1126\/science.1188015","volume":"329","author":"MG Vander Heiden","year":"2010","unstructured":"Vander Heiden, M. G. et al. Evidence for an alternative glycolytic pathway in rapidly proliferating cells. Science 329, 1492\u20131499 (2010).","journal-title":"Science"},{"key":"14788_CR52","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/cr.2016.159","volume":"27","author":"J Liang","year":"2017","unstructured":"Liang, J. et al. Mitochondrial PKM2 regulates oxidative stress-induced apoptosis by stabilizing Bcl2. Cell Res. 27, 329\u2013351 (2017).","journal-title":"Cell Res."},{"key":"14788_CR53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2013.11.001","volume":"53","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol. Cell 53, 75\u201387 (2014).","journal-title":"Mol. Cell"},{"key":"14788_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6566","volume":"5","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. PKM2 phosphorylates MLC2 and regulates cytokinesis of tumour cells. Nat. Commun. 5, 5566 (2014).","journal-title":"Nat. Commun."},{"key":"14788_CR55","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1126\/science.1211485","volume":"334","author":"D Anastasiou","year":"2011","unstructured":"Anastasiou, D. et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 334, 1278\u20131283 (2011).","journal-title":"Science"},{"key":"14788_CR56","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1001\/jama.1970.03180080143029","volume":"214","author":"SA Friedman","year":"1970","unstructured":"Friedman, S. A. Levodopa and pyridoxine-deficient states. Jama 214, 1563 (1970).","journal-title":"Jama"},{"key":"14788_CR57","unstructured":"van der Steen, W., den Heijer, T., Groen, J. Vitamin B6 deficiency caused by the use of levodopa]. Ned. Tijdschr. Geneeskd. 162, D2818 (2018)."},{"key":"14788_CR58","first-page":"81","volume":"94","author":"RC Duvoisin","year":"1969","unstructured":"Duvoisin, R. C., Yahr, M. D. & Cote, L. D. Pyridoxine reversal of L-dopa effects in Parkinsonism. Trans. Am. Neurol. Assoc. 94, 81\u201384 (1969).","journal-title":"Trans. Am. Neurol. Assoc."},{"key":"14788_CR59","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3358\/shokueishi.58.268","volume":"58","author":"Y Sato","year":"2017","unstructured":"Sato, Y., Yasumiishi, C., Chiba, T. & Umegaki, K. A systematic review to identify unacceptable intake levels of vitamin B6 among patients taking levodopa. Shokuhin Eiseigaku Zasshi 58, 268\u2013274 (2017).","journal-title":"Shokuhin Eiseigaku Zasshi"},{"key":"14788_CR60","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","volume":"203","author":"T Perry","year":"2007","unstructured":"Perry, T. et al. Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy. Exp. Neurol. 203, 293\u2013301 (2007).","journal-title":"Exp. Neurol."},{"key":"14788_CR61","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1212\/WNL.37.11.1729","volume":"37","author":"RL Albin","year":"1987","unstructured":"Albin, R. L. et al. Acute sensory neuropathy-neuronopathy from pyridoxine overdose. Neurology 37, 1729\u20131732 (1987).","journal-title":"Neurology"},{"key":"14788_CR62","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1212\/01.wnl.0000225050.57553.6d","volume":"67","author":"LM de Lau","year":"2006","unstructured":"de Lau, L. M., Koudstaal, P. J., Witteman, J. C., Hofman, A. & Breteler, M. M. Dietary folate, vitamin B12, and vitamin B6 and the risk of Parkinson disease. Neurology 67, 315\u2013318 (2006).","journal-title":"Neurology"},{"key":"14788_CR63","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1017\/S0007114510001005","volume":"104","author":"K Murakami","year":"2010","unstructured":"Murakami, K. et al. Dietary intake of folate, vitamin B6, vitamin B12 and riboflavin and risk of Parkinson\u2019s disease: a case-control study in Japan. Br. J. Nutr. 104, 757\u2013764 (2010).","journal-title":"Br. J. Nutr."},{"key":"14788_CR64","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3390\/nu7095333","volume":"7","author":"L Shen","year":"2015","unstructured":"Shen, L. Associations between B vitamins and Parkinson\u2019s disease. Nutrients 7, 7197\u20137208 (2015).","journal-title":"Nutrients"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14788-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14788-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T13:27:22Z","timestamp":1670246842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-14788-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,18]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["14788"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-14788-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,18]]},"assertion":[{"value":"3 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"941"}}